Scopus BioPharma Inc. (SCPS)
OTCMKTS: SCPS · Delayed Price · USD
0.0003
+0.0002 (200.00%)
Aug 23, 2024, 9:30 AM EDT - Market closed
Scopus BioPharma Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year Ending | TTM | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | 2017 |
---|---|---|---|---|---|---|---|
Cash & Equivalents | 0.36 | 0.12 | 7.94 | 1.83 | 0.04 | 0 | Upgrade
|
Cash & Short-Term Investments | 0.36 | 0.12 | 7.94 | 1.83 | 0.04 | 0 | Upgrade
|
Cash Growth | -68.69% | -98.43% | 333.54% | 4885.71% | 2113.67% | -98.95% | Upgrade
|
Other Receivables | - | - | - | - | - | 0.03 | Upgrade
|
Receivables | - | - | - | - | - | 0.03 | Upgrade
|
Prepaid Expenses | 0.13 | 0.27 | 0.24 | 0.14 | 0.08 | 0.1 | Upgrade
|
Other Current Assets | - | - | - | - | 0.65 | - | Upgrade
|
Total Current Assets | 0.5 | 0.39 | 8.18 | 1.97 | 0.77 | 0.13 | Upgrade
|
Property, Plant & Equipment | 0 | 0 | 0 | 0 | 0 | - | Upgrade
|
Total Assets | 0.5 | 0.39 | 8.19 | 1.97 | 0.77 | 0.13 | Upgrade
|
Accounts Payable | 0.17 | 0.18 | 0.12 | 0.09 | 0.16 | - | Upgrade
|
Accrued Expenses | 10.74 | 7.03 | 4.05 | 1.43 | 0.69 | 0.11 | Upgrade
|
Current Portion of Long-Term Debt | - | - | - | 2.28 | - | - | Upgrade
|
Other Current Liabilities | 0.09 | 0.25 | - | - | - | 0.02 | Upgrade
|
Total Current Liabilities | 11 | 7.45 | 4.17 | 3.81 | 0.85 | 0.14 | Upgrade
|
Total Liabilities | 11 | 7.45 | 4.17 | 3.81 | 0.85 | 0.14 | Upgrade
|
Common Stock | 0.04 | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | Upgrade
|
Additional Paid-In Capital | 48.62 | 46.52 | 45.54 | 14.22 | 3.58 | 0.94 | Upgrade
|
Retained Earnings | -58.13 | -53.06 | -41.46 | -14.5 | -3.64 | -0.95 | Upgrade
|
Comprensive Income & Other | 0.02 | -0.04 | -0.09 | -1.57 | -0.03 | -0.01 | Upgrade
|
Total Common Equity | -9.45 | -6.56 | 4.02 | -1.83 | -0.08 | -0.01 | Upgrade
|
Minority Interest | -1.05 | -0.5 | - | - | - | - | Upgrade
|
Shareholders' Equity | -10.5 | -7.06 | 4.02 | -1.83 | -0.08 | -0.01 | Upgrade
|
Total Liabilities & Equity | 0.5 | 0.39 | 8.19 | 1.97 | 0.77 | 0.13 | Upgrade
|
Total Debt | - | - | - | 2.28 | - | - | Upgrade
|
Net Cash (Debt) | 0.36 | 0.12 | 7.94 | -0.45 | 0.04 | 0 | Upgrade
|
Net Cash Growth | -68.69% | -98.43% | - | - | 2113.67% | -98.95% | Upgrade
|
Net Cash Per Share | 0.01 | 0.01 | 0.46 | -0.03 | 0.00 | 0.00 | Upgrade
|
Filing Date Shares Outstanding | 42.08 | 39.58 | 21.09 | 15.73 | 12.51 | 10.77 | Upgrade
|
Total Common Shares Outstanding | 39.78 | 21.09 | 21.09 | 14.58 | 12.51 | 10.77 | Upgrade
|
Working Capital | -10.51 | -7.06 | 4.01 | -1.83 | -0.09 | -0.01 | Upgrade
|
Book Value Per Share | -0.24 | -0.31 | 0.19 | -0.13 | -0.01 | -0.00 | Upgrade
|
Tangible Book Value | -9.45 | -6.56 | 4.02 | -1.83 | -0.08 | -0.01 | Upgrade
|
Tangible Book Value Per Share | -0.24 | -0.31 | 0.19 | -0.13 | -0.01 | -0.00 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.